London: A new vaccine against the chronic liver disease hepatitis C has shown promising results in an early-stage clinical trial in humans, British and Italian scientists said Wednesday.They said the experimental vaccine, which is based on a modified cold virus and was safety-tested in 41 people, generated immune responses similar to those seen in people who have a rare but natural defense against the disease.
FM Arun Jaitley presents budget in Parliament
What common people want from Modi govt budget
The history of Indian Budget
Marrow Donor Registry of India launches Gujarat chapter